Skip to main content
Haemato AG logo

Haemato AG — Investor Relations & Filings

Ticker · HAEK ISIN · DE000A289VV1 LEI · 529900Q3CGRYVCW7E340 F Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2013-04-02 Share Issue/Capital Cha…
Country DE Germany
Listing F HAEK

About Haemato AG

https://haemato.de/en/start.html

Haemato AG is a pharmaceutical company focused on the specialty pharma market, concentrating on treatments for chronic diseases and high-priced therapies. The company's business activities include the development, acquisition, licensing, and distribution of a product portfolio that comprises innovative patent-protected medicines, biosimilars, and generics. The portfolio also extends to narcotics, including cannabis products, as well as over-the-counter (OTC) products and special cosmetics. Haemato AG's primary therapeutic areas of focus are HIV/AIDS, neurology, oncology, rheumatology, and ophthalmology.

Recent filings

Filing Released Lang Actions
Windsor AG: Ausbau der Pharma Sparte
Share Issue/Capital Change Classification · 99% confidence The document is a 'Corporate News' announcement from WINDSOR AG dated April 2, 2013. The key subject matter revolves around the acquisition of shares in HAEMATO PHARM AG, a capital increase via the issuance of new shares to MPH Mittelständische Pharma Holding AG, and the resulting expansion of the Pharma division to over 200 million Euro in annual revenue. The announcement explicitly mentions a 'Sachkapitalerhöhung' (capital increase in kind) and the subsequent increase in shareholding. This directly relates to changes in the company's capital structure and fundraising activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full 10-K, an ER (which focuses on periodic results), or a DIRS (insider trading).
2013-04-02 German
Datum:22.02.2013
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Windsor AG for the fiscal year ending December 31, 2011. It contains a balance sheet (Bilanz) and detailed notes (Anhang) covering accounting principles, valuation methods, and specific breakdowns of assets, liabilities, and equity. As it provides comprehensive financial statements for a full fiscal year, it is classified as an Annual Report (10-K). FY 2011
2013-02-22 German
Windsor AG: 2012: Vorlaufiges IFRS-Ergebnis, Umsatz 24 Mio. Euro, Jahresuberschuss 7,5 Mio. Euro; Dividendenvorschlag: 25 Cent je Aktie
Notice of Dividend Amount Classification · 99% confidence The document is a short corporate news release dated January 25, 2013, announcing the 'Vorläufiges IFRS-Ergebnis' (Preliminary IFRS Result) for the fiscal year 2012. It highlights key figures like revenue (24 Mio. Euro), net profit (7.5 Mio. Euro), and proposes a dividend (25 Cent je Aktie). This content structure—a brief announcement of preliminary annual results and dividend proposal—is characteristic of an Earnings Release (ER), which typically provides the key highlights before the full Annual Report (10-K) or comprehensive Interim Report (IR) is filed. Although it contains annual results, its brevity and nature as an initial announcement strongly suggest ER over 10-K or AR. It is not a full transcript (CT), management discussion (MDA), or a formal proxy/dividend notice (DIV/DEF 14A), but rather the initial market communication of the results.
2013-01-25 German
Windsor AG: Q 3 2012: Umsatz 11,63 Mio. Euro; Gewinn 3,50 Mio. Euro
Earnings Release Classification · 100% confidence The document explicitly announces the financial results for the third quarter (Q3 2012) of WINDSOR AG, stating key figures like Umsatz (Revenue) of 11.63 Mio. Euro and Gewinn (Profit) of 3.50 Mio. Euro. It also provides year-to-date figures (January-September 2012). This content structure—a brief announcement highlighting key period results—perfectly matches the definition of an Earnings Release (ER). It is not a comprehensive Interim Report (IR) or Annual Report (10-K), nor is it a transcript (CT) or a presentation (IP). The short length and focus on headline figures confirm it is an initial release. Q3 2012
2012-11-12 German
Windsor AG: Wechsel im Vorstand
Board/Management Information Classification · 100% confidence The document is a short corporate news release dated May 25, 2012, titled "WINDSOR AG: Wechsel im Vorstand" (Change in the Management Board). It explicitly announces the appointment of Dr. Christian Pahl to the board and the resignation of Mr. Roy von der Locht. This content directly corresponds to the definition of Board/Management Information.
2012-05-25 German
Windsor AG: Das Unternehmen gibt den Erwerb von 52% am Kapital der Windsor AG durch die MPH Mittelstandische Pharma Holding AG bekannt
M&A Activity Classification · 98% confidence The document is a corporate news release dated May 7, 2012, announcing that MPH Mittelständische Pharma Holding AG acquired a majority stake (around 52%) in WINDSOR AG. The key phrases are "Mehrheitsübernahme" (majority takeover) and "Fusionen & Übernahmen/Kooperation" (Mergers & Acquisitions/Cooperation) in the keywords section. This clearly indicates an announcement related to a merger, acquisition, or takeover bid. According to the definitions, this corresponds to the M&A Activity category (TAR). The document length is relatively short (3865 chars) and functions as an announcement of a transaction, not a comprehensive report like a 10-K or IR.
2012-05-07 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.